JP6842089B2 - 抗生物質として有用なコロルマイシン誘導体 - Google Patents

抗生物質として有用なコロルマイシン誘導体 Download PDF

Info

Publication number
JP6842089B2
JP6842089B2 JP2017555587A JP2017555587A JP6842089B2 JP 6842089 B2 JP6842089 B2 JP 6842089B2 JP 2017555587 A JP2017555587 A JP 2017555587A JP 2017555587 A JP2017555587 A JP 2017555587A JP 6842089 B2 JP6842089 B2 JP 6842089B2
Authority
JP
Japan
Prior art keywords
vibrio
infection
peg
bacteria
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2017555587A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018513194A5 (enExample
JP2018513194A (ja
Inventor
ディブロフ，パベル
ディブロフ，エレナ
ピアース，グラント
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JP2018513194A publication Critical patent/JP2018513194A/ja
Publication of JP2018513194A5 publication Critical patent/JP2018513194A5/ja
Application granted granted Critical
Publication of JP6842089B2 publication Critical patent/JP6842089B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/66—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/30—Oxygen atoms, e.g. delta-lactones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/54—Quaternary phosphonium compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Furan Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2017555587A 2015-04-23 2016-04-22 抗生物質として有用なコロルマイシン誘導体 Active JP6842089B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562151902P 2015-04-23 2015-04-23
US62/151,902 2015-04-23
PCT/CA2016/050470 WO2016168938A1 (en) 2015-04-23 2016-04-22 Derivatives of korormicin useful as antibiotics

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021015712A Division JP7121225B2 (ja) 2015-04-23 2021-02-03 抗生物質として有用なコロルマイシン誘導体

Publications (3)

Publication Number Publication Date
JP2018513194A JP2018513194A (ja) 2018-05-24
JP2018513194A5 JP2018513194A5 (enExample) 2019-05-23
JP6842089B2 true JP6842089B2 (ja) 2021-03-17

Family

ID=57142747

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2017555587A Active JP6842089B2 (ja) 2015-04-23 2016-04-22 抗生物質として有用なコロルマイシン誘導体
JP2021015712A Active JP7121225B2 (ja) 2015-04-23 2021-02-03 抗生物質として有用なコロルマイシン誘導体
JP2022032136A Pending JP2022122857A (ja) 2015-04-23 2022-03-02 抗生物質として有用なコロルマイシン誘導体

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2021015712A Active JP7121225B2 (ja) 2015-04-23 2021-02-03 抗生物質として有用なコロルマイシン誘導体
JP2022032136A Pending JP2022122857A (ja) 2015-04-23 2022-03-02 抗生物質として有用なコロルマイシン誘導体

Country Status (8)

Country Link
US (5) US10166213B2 (enExample)
EP (1) EP3285762A4 (enExample)
JP (3) JP6842089B2 (enExample)
CN (2) CN116574132A (enExample)
AU (4) AU2016253429B2 (enExample)
CA (1) CA2983460A1 (enExample)
IL (2) IL255182B2 (enExample)
WO (1) WO2016168938A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2016253429B2 (en) * 2015-04-23 2019-01-03 Viotika Life Sciences Inc. Derivatives of korormicin useful as antibiotics
CN116617231B (zh) * 2023-06-12 2024-11-15 沈阳药科大学 2-氨基萘嵌间二氮杂苯氢溴化物增强对革兰氏阴性菌杀菌作用的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2315489A (en) * 1996-07-17 1998-02-04 Merck & Co Inc Antifungal agent
JP3905604B2 (ja) * 1997-03-04 2007-04-18 株式会社海洋バイオテクノロジー研究所 新規化学物質コロールミシン
JP2000281670A (ja) 1999-03-26 2000-10-10 Marine Biotechnol Inst Co Ltd 新規コロールミシン合成中間体及び製造法
JP2000336088A (ja) * 1999-05-27 2000-12-05 Marine Biotechnol Inst Co Ltd 新規化学物質Ｆ４２０ｍ類縁体
JP2001010908A (ja) * 1999-06-28 2001-01-16 Marine Biotechnol Inst Co Ltd 防汚剤
JP2003061645A (ja) 2001-08-23 2003-03-04 Marine Biotechnol Inst Co Ltd 海洋細菌の選択培地
WO2008116029A1 (en) * 2007-03-19 2008-09-25 Wisconsin Alumni Research Foundation Modulation of bacterial quorum sensing with synthetic ligands
EP2448930B1 (en) * 2009-07-03 2017-02-15 The National Institute for Biotechnology in the Negev Ltd. N-((S)-2-Oxo-tetrahydro-furan-3-yl)-amide derivatives as inhibitors of the bacterial quorum sensing for treating plant or animal diseases and for preventing the formation of biofilms on medical devices
AU2016253429B2 (en) * 2015-04-23 2019-01-03 Viotika Life Sciences Inc. Derivatives of korormicin useful as antibiotics

Also Published As

Publication number Publication date
JP2021073278A (ja) 2021-05-13
AU2020267205B2 (en) 2022-04-14
US20240358670A1 (en) 2024-10-31
US10166213B2 (en) 2019-01-01
JP2022122857A (ja) 2022-08-23
EP3285762A1 (en) 2018-02-28
EP3285762A4 (en) 2019-02-06
AU2022204906A1 (en) 2022-07-28
JP7121225B2 (ja) 2022-08-18
AU2016253429A1 (en) 2017-12-07
CN116574132A (zh) 2023-08-11
IL255182B2 (en) 2024-06-01
AU2016253429B2 (en) 2019-01-03
AU2022204906B2 (en) 2024-03-28
WO2016168938A1 (en) 2016-10-27
US20200345682A1 (en) 2020-11-05
IL255182B1 (en) 2024-02-01
IL255182A0 (en) 2017-12-31
US20180064680A1 (en) 2018-03-08
AU2019202254A1 (en) 2019-05-02
AU2019202254B2 (en) 2020-08-13
US11324716B2 (en) 2022-05-10
JP2018513194A (ja) 2018-05-24
US10744111B2 (en) 2020-08-18
US12029716B2 (en) 2024-07-09
US20220257555A1 (en) 2022-08-18
CA2983460A1 (en) 2016-10-27
US20190083450A1 (en) 2019-03-21
CN107708689A (zh) 2018-02-16
AU2020267205A1 (en) 2020-12-10
IL310102A (en) 2024-03-01

Similar Documents

Publication Publication Date Title
Denis et al. Targeting Type IV pili as an antivirulence strategy against invasive meningococcal disease
Qin et al. Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics
US20240358670A1 (en) Derivatives of korormicin useful as antibiotics
AU2003267079B2 (en) Factors that bind intestinal toxins
WO2021109549A1 (zh) 一种槲皮素与抗菌药物的联合应用
Song et al. Dual effects of feed-additive-derived chelerythrine in combating mobile colistin resistance
Lv et al. Myricetin inhibits the type III secretion system of Salmonella enterica serovar typhimurium by downregulating the Salmonella pathogenic island I gene regulatory pathway
US20090186949A1 (en) Method for Treating Endothelial and Epithelial Cell Disorders by Administering High Molecular Weight PEG-Like Compounds
Chi et al. Berberine protects against dysentery by targeting both Shigella filamentous temperature sensitive protein Z and host pyroptosis: Resolving in vitro–vivo effect discrepancy
Liu et al. Immunomodulator AS101 restores colistin susceptibility of clinical colistin-resistant Escherichia coli and Klebsiella pneumoniae in vitro and in vivo
Weawsiangsang et al. Investigating antibacterial mechanisms of hydroquinine against Pseudomonas aeruginosa and its application as preventive contact lens solution
Peng et al. Plant phenolic acids enhance antibiotic efficacy against multidrug-resistant extraintestinal pathogenic Escherichia coli
Wang et al. MDM2-P53-V-ATPases axis driven by dehydroevodiamine to fight intracellular bacterial infection
Palma et al. Anti-virulence activity and immunomodulation of Oreoch-1 against enteroinvasive Escherichia coli infection
Pointon Copper homeostasis and Salmonella pathogenicity: Interplay with resistance to nitrosative stress
Tsai Exploiting Host Immunity for Anti-infective Discovery in Salmonella Typhimurium
HK40087860A (zh) Capsaicyns在治疗肠漏中的应用
Yrjänheikki Assay Setup for High Throughput Screening to Identify Novel Efflux Pump Inhibitors against Escherichia coli
JP2023552079A (ja) リーキーガット（腸管壁侵漏）の治療におけるカプサイシン
Viau Pmrab-regulated lps phosphoethanolamine modifications have multiple roles in citrobacter rodentium
Osborne Antimicrobials and antimicrobial resistance: two studies investigating different ways to tackle the issue

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190411

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20190411

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190412

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20200130

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20200204

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20200410

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20200624

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200803

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20210105

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20210203

R150 Certificate of patent or registration of utility model

Ref document number: 6842089

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250